274 related articles for article (PubMed ID: 18333314)
1. Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug.
Suleyman H; Cadirci E; Albayrak A; Halici Z
Curr Med Chem; 2008; 15(3):278-83. PubMed ID: 18333314
[TBL] [Abstract][Full Text] [Related]
2. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
Hochberg MC
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
[TBL] [Abstract][Full Text] [Related]
3. [Nimesulide - a non-steroidal anti-inflammatory drug, a preferential cyclooxygenase-2 inhibitor].
Bennett A; Vila D
Vutr Boles; 2000; 32(1):33-6. PubMed ID: 11195195
[TBL] [Abstract][Full Text] [Related]
4. [Nimesulide (Aulin)--the selective COX-2 inhibitor in the treatment of ENT diseases].
Arcimowicz M; Samoliński B; Gotlib T; Nyckowska J
Otolaryngol Pol; 2002; 56(4):501-7. PubMed ID: 12378813
[TBL] [Abstract][Full Text] [Related]
5. Nimesulide: an NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities.
Bennett A; Villa G
Expert Opin Pharmacother; 2000 Jan; 1(2):277-86. PubMed ID: 11249549
[TBL] [Abstract][Full Text] [Related]
6. Selective cyclooxygenase-2 inhibitors for the treatment of arthritis.
Fung HB; Kirschenbaum HL
Clin Ther; 1999 Jul; 21(7):1131-57. PubMed ID: 10463513
[TBL] [Abstract][Full Text] [Related]
7. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study.
Mamdani M; Juurlink DN; Lee DS; Rochon PA; Kopp A; Naglie G; Austin PC; Laupacis A; Stukel TA
Lancet; 2004 May; 363(9423):1751-6. PubMed ID: 15172772
[TBL] [Abstract][Full Text] [Related]
8. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
Famaey JP
Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract.
Bjarnason I; Thjodleifsson B
Rheumatology (Oxford); 1999 May; 38 Suppl 1():24-32. PubMed ID: 10369403
[TBL] [Abstract][Full Text] [Related]
11. [COX-2 inhibitor non-steroidal anti-inflammatory drugs, myth or reality?].
Peretz A
Rev Med Brux; 2001 Sep; 22(4):A377-80. PubMed ID: 11680204
[TBL] [Abstract][Full Text] [Related]
12. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
Galli G; Panzetta G
G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
[TBL] [Abstract][Full Text] [Related]
13. [Selective cyclooxygenase-2 inhibitors and the digestive tract].
Chaabouni H; Amouri A; Cheikh I; Kchaou M; Ouerghi H; Ben Mami N; Ben Ammar A
Tunis Med; 2002 Aug; 80(8):427-33. PubMed ID: 12703120
[TBL] [Abstract][Full Text] [Related]
14. The relatively selective cyclooxygenase-2 inhibitor nimesulide: What's going on?
Caiazzo E; Ialenti A; Cicala C
Eur J Pharmacol; 2019 Apr; 848():105-111. PubMed ID: 30689999
[TBL] [Abstract][Full Text] [Related]
15. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibitors of COX-2--are they safe for the stomach?
Giercksky KE; Haglund U; Rask-Madsen J
Scand J Gastroenterol; 2000 Nov; 35(11):1121-4. PubMed ID: 11145280
[TBL] [Abstract][Full Text] [Related]
17. Nimesulide: some pharmaceutical and pharmacological aspects--an update.
Singla AK; Chawla M; Singh A
J Pharm Pharmacol; 2000 May; 52(5):467-86. PubMed ID: 10864134
[TBL] [Abstract][Full Text] [Related]
18. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
;
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
[TBL] [Abstract][Full Text] [Related]
19. Are rofecoxib and celecoxib safer NSAIDS?
Drug Ther Bull; 2000 Nov; 38(11):81-6. PubMed ID: 11138599
[TBL] [Abstract][Full Text] [Related]
20. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
Bertolini A; Ottani A; Sandrini M
Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
